Childhood Acute Lymphoblastic Leukemia in Remission: Clinical Trials

42 trials for Childhood Acute Lymphoblastic Leukemia in Remission, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

41 completed, 1 unknown. 21 Phase 2, 10 Not applicable, 4 Phase 1, 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 221Completed 21
Not applicable10Completed 10
Phase 14Completed 4
Phase 34Completed 4

Follow Childhood Acute Lymphoblastic Leukemia in Remission: new trials by email Literature Review of Childhood Acute Lymphoblastic Leukemia in Remission trials Research Report on Childhood Acute Lymphoblastic Leukemia in Remission

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Creating a Decision Support System for the Corporate Management of Physical Therapy
Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Brain Tumor
UnknownFederal Research Institute of Pediatric Hematology, Oncology and Immunology10002017-11-012018-07-13
Culturally Adapted Parenting Intervention for Spanish-Speaking Parents in Improving Outcomes of Younger Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia Survivors at Risk for Late Neurocognitive Effects
Educational Intervention, Quality-of-Life Assessment, Questionnaire Administration - Cancer Survivor, Childhood Acute Lymphoblastic Leukemia in Remission
Not applicableCompletedCity of Hope Medical Center382015-10-232026-10-09
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD
Allogeneic Hematopoietic Stem Cell Transplantation, Cyclophosphamide, Fludarabine Phosphate - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia
Phase 2CompletedFred Hutchinson Cancer Center842015-03-232026-06-01
Let's Play! Healthy Kids After Cancer
Phone Coaching Program - Childhood Acute Lymphoblastic Leukemia in Remission, Obesity
Not applicableCompletedHealthPartners Institute422015-02-012019-06-10
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children
Allogeneic Hematopoietic Stem Cell Transplantation, Fludarabine Phosphate, Laboratory Biomarker Analysis - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia
Phase 2CompletedFred Hutchinson Cancer Center202014-04-102024-03-12
ALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia Patients
nutritional intervention, exercise intervention, follow-up care - Childhood Acute Lymphoblastic Leukemia in Remission
Not applicableCompletedVanderbilt-Ingram Cancer Center332013-05-012018-05-08
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
fludarabine phosphate, melphalan, total-body irradiation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 2CompletedRoswell Park Cancer Institute942012-02-282019-09-24
Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia
laboratory biomarker analysis - B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission
CompletedChildren's Oncology Group702012-02-012016-05-18
Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies
cyclophosphamide, cyclosporine, peripheral blood stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 2CompletedFred Hutchinson Cancer Center432011-09-012017-05-19
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Fludarabine, Busulfan, Total Body Irradiation (TBI) - Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission
Phase 2CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University402011-08-042026-04-15
Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
supersaturated calcium phosphate rinse, placebo, questionnaire administration - Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission
Phase 3CompletedChildren's Oncology Group2262011-03-012019-09-17
Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies
umbilical cord blood transplantation, fludarabine phosphate, cyclophosphamide - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission
Phase 2CompletedNohla Therapeutics, Inc.152010-08-012019-03-05
Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer
massage therapy, questionnaire administration, quality-of-life assessment - Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia
Not applicableCompletedWake Forest University Health Sciences802010-04-012018-07-02
Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia
treosulfan, fludarabine phosphate, total-body irradiation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 2CompletedFred Hutchinson Cancer Center962009-02-012021-06-22
Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure Disorders
fludarabine phosphate, melphalan, total-body irradiation - Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Not applicableCompletedRoswell Park Cancer Institute622009-01-142019-11-13
Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML
nilotinib, imatinib mesylate, pharmacological study - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 1 / Phase 2CompletedFred Hutchinson Cancer Center402008-08-142017-08-10
Donor Bone Marrow Transplant With or Without G-CSF in Treating Young Patients With Hematologic Cancer or Other Diseases
allogeneic bone marrow transplantation, laboratory biomarker analysis, filgrastim - Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission
Phase 3CompletedChildren's Oncology Group272007-12-312022-04-28
Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
double-unit umbilical cord blood transplantation, cytogenetic analysis, bone marrow aspiration - Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission
Phase 2CompletedCase Comprehensive Cancer Center142007-09-012019-01-23
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
beclomethasone dipropionate, placebo, tacrolimus - Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia
Phase 2CompletedFred Hutchinson Cancer Center1402007-04-012021-02-03
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
thiotepa, cyclophosphamide, tacrolimus - B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission
Phase 3CompletedChildren's Oncology Group1462007-03-012019-08-07

Showing 20 of 42. Sign in to see all of them.

Narrower conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma (35)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (20)  ·  Leukemia, Myeloid, Accelerated Phase (20)  ·  Burkitt Lymphoma (19)  ·  Leukemia, Myeloid, Acute (19)  ·  Lymphoma, Non-Hodgkin (19)  ·  Leukemia, Myeloid, Chronic-Phase (18)  ·  Lymphoma, B-Cell, Marginal Zone (18)  ·  Lymphoma, Follicular (18)  ·  Multiple Myeloma (18)  ·  Congenital Abnormalities (17)  ·  Dendritic Cell Sarcoma, Interdigitating (17)  ·  Hodgkin Disease (17)  ·  Lymphoma, Large B-Cell, Diffuse (17)  ·  Lymphoma, T-Cell, Cutaneous (17)

Broader conditions

Hematologic Diseases (37)  ·  Hemic and Lymphatic Diseases (37)  ·  Neoplasms (37)  ·  Neoplasms by Histologic Type (37)  ·  Immune System Diseases (35)  ·  Immunoproliferative Disorders (35)  ·  Leukemia (35)  ·  Leukemia, Lymphoid (35)  ·  Lymphatic Diseases (35)  ·  Lymphoproliferative Disorders (35)  ·  Leukemia, Myeloid (30)  ·  Pathological Conditions, Signs and Symptoms (30)  ·  Bone Marrow Diseases (29)  ·  Chronic Disease (29)  ·  Disease Attributes (29)

Interventions

Whole-Body Irradiation (21)  ·  fludarabine phosphate (21)  ·  Mycophenolic Acid (18)  ·  Peripheral Blood Stem Cell Transplantation (17)  ·  Cyclosporine (15)  ·  Cyclophosphamide (11)  ·  Tacrolimus (10)  ·  Methotrexate (9)  ·  merphos (9)  ·  Transplantation (8)  ·  Busulfan (6)  ·  Cyclosporins (4)  ·  Melphalan (4)  ·  Thiotepa (4)  ·  Cord Blood Stem Cell Transplantation (3)

Sponsors

Fred Hutchinson Cancer Center (18)  ·  Children's Oncology Group (9)  ·  Roswell Park Cancer Institute (3)  ·  Case Comprehensive Cancer Center (2)  ·  City of Hope Medical Center (1)  ·  Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1)  ·  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (1)  ·  HealthPartners Institute (1)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  National Cancer Institute (NCI) (1)  ·  Nohla Therapeutics, Inc. (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)  ·  Vanderbilt-Ingram Cancer Center (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (41)  ·  Germany (5)  ·  Italy (5)  ·  Australia (3)  ·  Canada (3)  ·  Denmark (1)  ·  Russia (1)

Top investigators

Brenda Sandmaier (5)  ·  Colleen Delaney (2)  ·  David Maloney (2)  ·  George Chen (2)  ·  George Georges (2)  ·  Marie Bleakley (2)  ·  Paul Martin (2)  ·  Adam Esbenshade, MD (1)  ·  Alicia S Kunin-Batson, PhD (1)  ·  Ann Woolfrey (1)  ·  Boglarka Gyurkocza (1)  ·  Brenda Cooper, MD (1)  ·  Christen Ebens, MD (1)  ·  David Gilbert, MD (1)  ·  Gregory Yanik, MD (1)

Results publications

PMID 32499241, PMID 35007144, PMID 18698002, PMID 21508120, PMID 24497539, PMID 24829202, PMID 25085357, PMID 25624441, PMID 25862561, PMID 26764356, PMID 28817727, PMID 33242441, PMID 35445027, PMID 37070673, PMID 40908865

NIH funding

P30CA015704 (12), P01CA018029 (10), U10CA098543 (6), P01CA078902 (2), R01HL121568 (2), RC2HL101844 (2), U10CA095861 (2), K12CA090625 (1), K23CA154532 (1), P01HL036444 (1), P30CA016056 (1), P30CA068485 (1), R01CA076641 (1), R01CA096670 (1), R21CA182727 (1)